Analyst Ratings for Magellan Health Inc. (MGLN)

Updated: 2017-07-27

Shares of Magellan Health Inc. (NASDAQ:MGLN) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MGLN last month.

2 analysts declared MGLN a buy, 0 gave an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Several price targets were given for MGLN by the analysts covering the stock. The most optimistic price target was 91, which equates to a potential upside of 15.63 percent. The most pessimistic price target was 69, which equates to a potential downside of -12.33 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Analysts have revised their earnings estimates downwards for this quarter, by about -6.2 percent on average, compared to last month. That number becomes -2.19 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised downwards by -3.8 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 1.86 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 1 analysts decreased their estimates.

MGLN has an estimated earnings growth rate of 27.6 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of MGLN is 0.82.

MGLN has a 52-week high of 84.71 and a 52-week low of 49.50. The current market price is above the trailing year's low by 58.99 percent, and below the high by 7.09 percent. MGLN has a price/earnings ratio of 22.7. Investors typically compare the P/E ratio to a company's peers in the industry. The MGLN value stock report compares MGLN to some of its peers using value stock charts. The stock has a market capitalization of $1.88 billion. MGLN will post this quarters earnings in days, on 0000-00-00.